James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Intrexon, LendingClub and CA Technologies Are 3 of Today’s Worst Stocks

Intrexon Corp., LendingClub Corporation and CA Technologies, Inc. used more than their fair share of red ink on Wednesday. Here's the deal.

IBM Stock: Is This Earnings Dip an Opportunity … or an Omen?

It would be easy for contrarians to love the fact that most everyone hates IBM stock right now, but sometimes, the market's collective guess is exactly right.

Why Wynn Resorts, SAP and Kite Pharma Are 3 of Today’s Worst Stocks

Wynn Resorts, Limited, SAP SE and Juno Therapeutics Inc. led the bearish charge today. Here's what investors will want to know.

The Rally From Chinese Stocks Just Hit a Roadblock

Chinese stocks were on fire last year, but the one thing fanning those flames was just taken out of the equation... margin trading rules that weren't well enforced.

Why Precision Castparts, Regal Entertainment and SolarCity Are 3 of Today’s Worst Stocks

Precision Castparts, Regal Entertainment and SolarCity got whacked rather hard to close out the week. Here's the deal.

How Long Can Gold Prices Keep Rising?

Gold prices have quietly turned bullish over the past several weeks, even though all clues point to bearishness. Should we heed the defiant move as a clue of what's coming?

Why BlackBerry, Best Buy and D.R. Horton Are 3 of Today’s Worst Stocks

Best Buy, BlackBerry and D.R. Horton led Thursday's bearish charge, though given the news, it can't be surprising.

5 Biotech Stocks With Explosive Drug Pipelines

For many biotech stocks, drug pipelines -- not trailing results -- determine their actual value. That's good news for investors in these 5 biotechs.

Luxury Stocks Don’t Start 2015 on an Encouraging Foot

Recent news headlines from Michael Kors Holdings Ltd, Tiffany & Co. and Coach Inc. may be pointing to major headwinds for luxury stocks.

Why Century Aluminum, Tesla Motors and Foot Locker Are 3 of Today’s Worst Stocks

Foot Locker, Century Aluminum and Tesla Motors tumbled more than most stocks did during Wednesday's selloff. Here's what investors need to know.